Do analysts prefer DRMA or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dermata Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate SNYR or ATPC?

Synergy CHC presently has a consensus target price of $6.25, indicating a potential upside of 6,112.72%. Given Synergy CHC's stronger consensus rating and higher probable upside, analysts clearly believe Synergy CHC is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SNYR or ATPC more profitable?

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Agape ATP -85.94% -5.47% -4.94%

Do analysts rate DSYWW or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Big Tree Cloud 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, DSYWW or ATPC?

Big Tree Cloud has higher revenue and earnings than Agape ATP. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Big Tree Cloud $2.02M N/A N/A N/A N/A Agape ATP $1.52M 1.57 -$2.28M -$0.74 N/A

Do analysts rate DRMAW or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dermata Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, DRMAW or ATPC?

Dermata Therapeutics has higher earnings, but lower revenue than Agape ATP. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dermata Therapeutics N/A N/A N/A N/A N/A Agape ATP $1.52M 1.57 -$2.28M -$0.74 N/A

Do analysts rate ATPC or PRENW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Prenetics Global 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, ATPC or PRENW?

Prenetics Global has higher revenue and earnings than Agape ATP. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 1.57 -$2.28M -$0.74 N/A Prenetics Global $154.59M N/A N/A N/A N/A

Agape ATP (ATPC) Competitors

$2.38 +0.01 (+0.42%)

Closing price 09/11/2026 03:48 PM Eastern

Extended Trading

$2.34 -0.04 (-1.68%)

As of 09/11/2026 07:30 PM Eastern

Compare

ATPC vs. DRMA, SNYR, DSYWW, DRMAW, and PRENW

Should you buy Agape ATP stock or one of its competitors? Agape ATP's main competitors and comparable companies include Dermata Therapeutics (DRMA), Synergy CHC (SNYR), Big Tree Cloud (DSYWW), Dermata Therapeutics (DRMAW), and Prenetics Global (PRENW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Agape ATP compare to Dermata Therapeutics?

Dermata Therapeutics (NASDAQ:DRMA) and Agape ATP (NASDAQ:ATPC) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

Dermata Therapeutics has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market.

Dermata Therapeutics has a net margin of 0.00% compared to Agape ATP's net margin of -85.94%. Agape ATP's return on equity of -5.47% beat Dermata Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dermata Therapeutics	N/A	-166.66%	-130.13%
Agape ATP	-85.94%	-5.47%	-4.94%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dermata Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has higher revenue and earnings than Dermata Therapeutics. Agape ATP is trading at a lower price-to-earnings ratio than Dermata Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dermata Therapeutics	N/A	N/A	-$7.56M	-$4.39	N/A
Agape ATP	$1.52M	1.57	-$2.28M	-$0.74	N/A

8.7% of Dermata Therapeutics shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 21.9% of Dermata Therapeutics shares are held by company insiders. Comparatively, 2.0% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Dermata Therapeutics had 1 more articles in the media than Agape ATP. MarketBeat recorded 2 mentions for Dermata Therapeutics and 1 mentions for Agape ATP. Agape ATP's average media sentiment score of 1.89 beat Dermata Therapeutics' score of 1.44 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Overall Sentiment
Dermata Therapeutics	Positive
Agape ATP	Very Positive

Summary

Dermata Therapeutics and Agape ATP tied by winning 6 of the 12 factors compared between the two stocks.

How does Agape ATP compare to Synergy CHC?

Synergy CHC (NASDAQ:SNYR) and Agape ATP (NASDAQ:ATPC) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Agape ATP has lower revenue, but higher earnings than Synergy CHC. Agape ATP is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$30.38M	0.05	-$12.34M	-$1.40	N/A
Agape ATP	$1.52M	1.57	-$2.28M	-$0.74	N/A

Synergy CHC has a beta of -0.25, suggesting that its share price is 125% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market.

0.0% of Agape ATP shares are held by institutional investors. 32.9% of Synergy CHC shares are held by insiders. Comparatively, 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Synergy CHC and Synergy CHC both had 1 articles in the media. Agape ATP's average media sentiment score of 1.89 beat Synergy CHC's score of 1.87 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Overall Sentiment
Synergy CHC	Very Positive
Agape ATP	Very Positive

Synergy CHC presently has a consensus target price of $6.25, indicating a potential upside of 6,112.72%. Given Synergy CHC's stronger consensus rating and higher probable upside, analysts clearly believe Synergy CHC is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Agape ATP	-85.94%	-5.47%	-4.94%

Summary

Synergy CHC beats Agape ATP on 8 of the 15 factors compared between the two stocks.

How does Agape ATP compare to Big Tree Cloud?

Big Tree Cloud (NASDAQ:DSYWW) and Agape ATP (NASDAQ:ATPC) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

Big Tree Cloud has a net margin of 0.00% compared to Agape ATP's net margin of -85.94%. Big Tree Cloud's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Big Tree Cloud	N/A	N/A	N/A
Agape ATP	-85.94%	-5.47%	-4.94%

Big Tree Cloud has higher revenue and earnings than Agape ATP.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Big Tree Cloud	$2.02M	N/A	N/A	N/A	N/A
Agape ATP	$1.52M	1.57	-$2.28M	-$0.74	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Big Tree Cloud	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

0.0% of Agape ATP shares are owned by institutional investors. 2.0% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Big Tree Cloud and Big Tree Cloud both had 1 articles in the media. Big Tree Cloud's average media sentiment score of 1.89 equaled Agape ATP'saverage media sentiment score.

Company	Overall Sentiment
Big Tree Cloud	Very Positive
Agape ATP	Very Positive

Summary

Big Tree Cloud beats Agape ATP on 4 of the 7 factors compared between the two stocks.

How does Agape ATP compare to Dermata Therapeutics?

Dermata Therapeutics (NASDAQ:DRMAW) and Agape ATP (NASDAQ:ATPC) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Dermata Therapeutics has higher earnings, but lower revenue than Agape ATP.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dermata Therapeutics	N/A	N/A	N/A	N/A	N/A
Agape ATP	$1.52M	1.57	-$2.28M	-$0.74	N/A

In the previous week, Agape ATP had 1 more articles in the media than Dermata Therapeutics. MarketBeat recorded 1 mentions for Agape ATP and 0 mentions for Dermata Therapeutics. Agape ATP's average media sentiment score of 1.89 beat Dermata Therapeutics' score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Overall Sentiment
Dermata Therapeutics	Neutral
Agape ATP	Very Positive

0.0% of Agape ATP shares are owned by institutional investors. 2.0% of Agape ATP shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dermata Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Dermata Therapeutics has a net margin of 0.00% compared to Agape ATP's net margin of -85.94%. Dermata Therapeutics' return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dermata Therapeutics	N/A	N/A	N/A
Agape ATP	-85.94%	-5.47%	-4.94%

Summary

Agape ATP beats Dermata Therapeutics on 6 of the 9 factors compared between the two stocks.

How does Agape ATP compare to Prenetics Global?

Agape ATP (NASDAQ:ATPC) and Prenetics Global (NASDAQ:PRENW) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Prenetics Global	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Prenetics Global has higher revenue and earnings than Agape ATP.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	1.57	-$2.28M	-$0.74	N/A
Prenetics Global	$154.59M	N/A	N/A	N/A	N/A

Prenetics Global has a net margin of 0.00% compared to Agape ATP's net margin of -85.94%. Prenetics Global's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-85.94%	-5.47%	-4.94%
Prenetics Global	N/A	N/A	N/A

In the previous week, Agape ATP and Agape ATP both had 1 articles in the media. Agape ATP's average media sentiment score of 1.89 beat Prenetics Global's score of 1.87 indicating that Agape ATP is being referred to more favorably in the media.

Company	Overall Sentiment
Agape ATP	Very Positive
Prenetics Global	Very Positive

0.0% of Agape ATP shares are held by institutional investors. 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Agape ATP and Prenetics Global tied by winning 4 of the 8 factors compared between the two stocks.

Get Agape ATP News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATPC vs. The Competition

Export

Metric	Agape ATP	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$2.38M	$22.89B	$15.57B	$12.85B
Dividend Yield	N/A	4.52%	3.27%	11.17%
P/E Ratio	-3.22	20.30	14.06	25.36
Price / Sales	1.57	12.49	262,948.62	116.82
Price / Cash	N/A	27.06	56.87	51.52
Price / Book	0.11	2.88	4.76	6.20
Net Income	-$2.28M	$1.13B	$837.55M	$358.50M
7 Day Performance	-0.42%	-1.85%	-1.42%	-2.35%
1 Month Performance	-4.80%	-1.57%	-1.79%	-3.23%
1 Year Performance	-96.40%	-15.14%	10.48%	8.79%

Agape ATP Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATPC Agape ATP	0.9815 of 5 stars	$2.38 +0.4%	N/A	-96.4%	$2.38M	$1.52M	N/A	40	Positive News
DRMA Dermata Therapeutics	1.1453 of 5 stars	$1.21 -3.2%	N/A	-78.0%	$5.03M	N/A	N/A	8	Short Interest Decrease
SNYR Synergy CHC	3.6686 of 5 stars	$0.08 -0.6%	$6.25 +7,457.4%	-95.3%	$1.25M	$30.38M	N/A	40	Analyst Upgrade High Trading Volume
DSYWW Big Tree Cloud	N/A	$0.02 +3.1%	N/A	-55.4%	$0.00	$2.02M	N/A	82	Gap Up
DRMAW Dermata Therapeutics	N/A	$0.00 flat	N/A	-96.3%	$0.00	N/A	N/A	8	Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATPC) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agape ATP (ATPC) Competitors

ATPC vs. DRMA, SNYR, DSYWW, DRMAW, and PRENW

How does Agape ATP compare to Dermata Therapeutics?

Summary

How does Agape ATP compare to Synergy CHC?

Summary

How does Agape ATP compare to Big Tree Cloud?

Summary

How does Agape ATP compare to Dermata Therapeutics?

Summary

How does Agape ATP compare to Prenetics Global?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agape ATP (ATPC) Competitors

ATPC vs. DRMA, SNYR, DSYWW, DRMAW, and PRENW

How does Agape ATP compare to Dermata Therapeutics?

Which has more volatility and risk, DRMA or ATPC?

Is DRMA or ATPC more profitable?

Do analysts prefer DRMA or ATPC?

Which has stronger earnings & valuation, DRMA or ATPC?

Do institutionals & insiders have more ownership in DRMA or ATPC?

Does the media favor DRMA or ATPC?

Summary

How does Agape ATP compare to Synergy CHC?

Which has higher earnings and valuation, SNYR or ATPC?

Which has more volatility & risk, SNYR or ATPC?

Do insiders and institutionals have more ownership in SNYR or ATPC?

Does the media favor SNYR or ATPC?

Do analysts rate SNYR or ATPC?

Is SNYR or ATPC more profitable?

Summary

How does Agape ATP compare to Big Tree Cloud?

Is DSYWW or ATPC more profitable?

Which has preferable earnings & valuation, DSYWW or ATPC?

Do analysts rate DSYWW or ATPC?

Do insiders & institutionals have more ownership in DSYWW or ATPC?

Does the media favor DSYWW or ATPC?

Summary

How does Agape ATP compare to Dermata Therapeutics?

Which has better valuation & earnings, DRMAW or ATPC?

Does the media favor DRMAW or ATPC?

Do institutionals and insiders have more ownership in DRMAW or ATPC?

Do analysts rate DRMAW or ATPC?

Is DRMAW or ATPC more profitable?

Summary

How does Agape ATP compare to Prenetics Global?

Do analysts rate ATPC or PRENW?

Which has better earnings and valuation, ATPC or PRENW?

Is ATPC or PRENW more profitable?

Does the media favor ATPC or PRENW?

Do institutionals & insiders believe in ATPC or PRENW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools